Thermo Fisher Scientific expands its cell therapy development and manufacturing capabilities with new facility in San Francisco, CA.
The EU legislative framework is undergoing a period of substantial change to react to a seismic shift in scientific and technological advancements. During this three-part webinar series, we cover key areas sponsors must be mindful of during drug development in preparation for filing successful regulators submissions.
This webinar addresses the critical importance of the following:
This webinar discusses the five strategies to build a robust CMC package, help streamline the path to FIH trials for biologics and establish the quality foundation needed to support all of the development phases toward commercialization including :
This webinar provides key advice for determining and navigating the regulatory pathway for any cell and gene therapy, including the following: